Cargando…
The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials
AIM OF THE REVIEW: To describe the significant improvement in the diagnosis, treatment and outcome of children diagnosed with hepatoblastoma (HB) that has occurred in the past four decades. Recent findings are mainly focused on lessons learned from the experiences of the Childhood Liver Tumors Strat...
Autores principales: | Aronson, Daniel C, Czauderna, Piotr, Maibach, Rudolf, Perilongo, Giorgio, Morland, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204244/ https://www.ncbi.nlm.nih.gov/pubmed/25336801 http://dx.doi.org/10.4103/0971-9261.142001 |
Ejemplares similares
-
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study
por: Zsiros, József, et al.
Publicado: (2013) -
2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group
por: Roebuck, Derek J., et al.
Publicado: (2006) -
Hepatoblastoma: current understanding, recent advances, and controversies
por: Czauderna, Piotr, et al.
Publicado: (2018) -
Surgical management in hepatoblastoma: points to take
por: Murawski, Maciej, et al.
Publicado: (2023) -
HGF/c-Met related activation of β-catenin in hepatoblastoma
por: Purcell, Rachel, et al.
Publicado: (2011)